about
Characterization of new substrates targeted by Yersinia tyrosine phosphatase YopHImmunization of mice with YscF provides protection from Yersinia pestis infectionsThe twin arginine translocation system is essential for virulence of Yersinia pseudotuberculosis.Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidatesEvaluation of combinatorial vaccines against anthrax and plague in a murine modelBroad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plagueAntibody against V antigen prevents Yop-dependent growth of Yersinia pestis.Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infectionAnti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA.Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challengeSerum cytokine responses in primary pneumonic plague patientsConstruction and characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agents, Bacillus anthracis, Yersinia pestis, Burkholderia mallei, and Burkholderia pseudomalleiThe dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background.The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection.A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.Model systems to study plague pathogenesis and develop new therapeuticsDevelopment of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestisIntranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plagueA protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.Intraspecific diversity of Yersinia pestis.Protection against pneumonic plague following oral immunization with a non-replicating vaccine.A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells.Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice.Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.Yersinia pestis caf1 variants and the limits of plague vaccine protection.Biogenesis of the fraction 1 capsule and analysis of the ultrastructure of Yersinia pestis
P2860
Q21143870-CB00F585-995A-4FE1-AF2C-E0DB59FCF3F6Q24815169-E04ED5FB-7EF0-48EC-965E-4825977F0BC0Q28768225-E2256A14-031A-4BDB-8D3C-2C6986AB8EB6Q30414497-838DC48C-3524-4E3A-80F4-1DEB19D70875Q31037921-5188CADE-62A2-46C1-AD47-F9DA8478A058Q33283821-02AD4727-3669-41EA-A7D7-BA9F7618028FQ33310431-017EE726-8352-4809-9325-E10592FB7D5CQ33603015-9D3AF814-424C-45A6-AE38-EF40C1C775BCQ33612949-F030E14B-4A98-48B7-AE39-43D8E4295649Q33635050-D72A1D23-D6CD-4CBD-8D06-EAB7FC9521C3Q33637474-C602C89E-9513-4E2C-B07E-59F919896590Q33716043-AE04A9AD-B945-4B40-A21E-F681F44886AFQ33788149-A4150111-FAF2-46BD-BBB0-DC8308D2023FQ33826059-0E97A1C4-4937-40E1-AFE2-C31396572FFBQ34034184-C8B3642A-0741-48C7-8940-AD2596AC0DFFQ34045080-02E26D59-CAF9-4F20-96EF-1AE0489FFF1FQ34065115-EBC6E2DC-ADFC-4BAF-B368-D306A80BC9E1Q34123275-9307C873-EF9B-4FD7-8F84-5E77CF3C62C6Q34334406-602C1A1E-1807-4086-8BA0-0325B81A1EA6Q34394184-DF579915-024F-4E92-B4AD-49B67C73381CQ34457319-D120E95B-CE21-44D5-B1F7-E0988A6C6840Q34484087-169FACE8-F78F-410C-918D-DF2F78D64146Q34523864-7842BB9F-5EEB-4DB9-A987-3FBBB659FC6FQ34529535-0608CE54-7B33-46E4-B1E0-688BF201F0C8Q34681213-F37B1453-DF65-400C-AD11-868380C4421BQ34778198-CC3234AF-8710-4730-9EA4-BEDCEFE50957Q35029718-62F885EC-AA00-4662-BAA7-9AD58D614BBBQ35090599-5C7D2235-AED5-44E8-8DED-8093715B2407Q35530270-D02BBFF9-C99D-4F04-8133-B663B5BA6FDCQ35665414-CA74EBC8-FC74-4769-B837-D18EACFF80EFQ35745842-F0C38D89-69EE-4FFA-836A-6CA1EE13177CQ36099515-96098823-F2D3-4403-8BD5-1709361B7D8EQ36237899-02FF7381-249B-40D9-A3DD-D045533522A7Q36277431-3EFB73A3-473A-4173-BB05-ABF87ED503F7Q36315321-7D8D7120-2DCB-4208-A265-E969FE6202EEQ36513899-300680F6-8702-4633-B99C-2658718FB096Q36528895-AFB2F333-C164-4214-9819-91ACA6449C78Q36539626-79BE9623-C515-426A-AD28-EE0A2EDDC87BQ36594087-C4124642-09A4-4BBA-B6A2-CA39BD4B14BAQ36594569-AD106F02-1E4F-4993-B87E-B566366A94CD
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vaccination against bubonic and pneumonic plague.
@ast
Vaccination against bubonic and pneumonic plague.
@en
Vaccination against bubonic and pneumonic plague.
@nl
type
label
Vaccination against bubonic and pneumonic plague.
@ast
Vaccination against bubonic and pneumonic plague.
@en
Vaccination against bubonic and pneumonic plague.
@nl
prefLabel
Vaccination against bubonic and pneumonic plague.
@ast
Vaccination against bubonic and pneumonic plague.
@en
Vaccination against bubonic and pneumonic plague.
@nl
P1433
P1476
Vaccination against bubonic and pneumonic plague.
@en
P2093
Titball RW
Williamson ED
P304
P356
10.1016/S0264-410X(01)00163-3
P407
P577
2001-07-01T00:00:00Z